Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma

Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Ines Pombeiro, Catherine Leyh, Fabian Benz, Mihael Vucur, Thomas Longerich, Alexander Koch, Till Braunschweig, Tom F. Ulmer, Christoph Heidenhain, Frank Tacke, Marcel Binneboesel, Maximilian Schmeding, Christian Trautwein, Ulf P. Neumann, Tom Luedde*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)749-757
Number of pages9
JournalJournal of Hepatology
Volume67
Issue number4
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Cancer
  • Biomarker
  • Prognosis
  • CA19-9
  • CEA
  • CCA
  • Osteopontin
  • LONG-TERM SURVIVAL
  • INTRAHEPATIC CHOLANGIOCARCINOMA
  • PERIHILAR CHOLANGIOCARCINOMA
  • PANCREATIC ADENOCARCINOMA
  • HILAR CHOLANGIOCARCINOMA
  • PROGNOSTIC BIOMARKERS
  • INCREASING INCIDENCE
  • SERUM-LEVELS
  • CANCER
  • PROGRESSION

Cite this

Loosen, S. H., Roderburg, C., Kauertz, K. L., Pombeiro, I., Leyh, C., Benz, F., Vucur, M., Longerich, T., Koch, A., Braunschweig, T., Ulmer, T. F., Heidenhain, C., Tacke, F., Binneboesel, M., Schmeding, M., Trautwein, C., Neumann, U. P., & Luedde, T. (2017). Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma. Journal of Hepatology, 67(4), 749-757. https://doi.org/10.1016/j.jhep.2017.06.020